Get started
Author

Sergey V. Karakashev

Observed names: Sergey Karakashev, Sergey Karakashev (14934180)
ORCID: 0000-0002-9849-2714
Observed ORCID: 0000-0002-9849-2714
OpenAlex ID: A5038316543
N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor Resistance
2019 · Takeshi Fukumoto, Hengrui Zhu, et al. · Cancer Research · 181
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
2017 · Sergey Karakashev, Hengrui Zhu, et al. · Cell Reports · 174
PDF
EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition
2020 · Sergey Karakashev, Takeshi Fukumoto, et al. · Cancer Cell · 151
PDF
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma
2021 · Shuai Wu, Takeshi Fukumoto, et al. · Nature Cancer · 132
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer
2019 · Takeshi Fukumoto, Nail Fatkhutdinov, et al. · Cancer Research · 127
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
2018 · Takeshi Fukumoto, Pyoung Hwa Park, et al. · Cell Reports · 104
PDF
CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity
2018 · Sergey Karakashev, Hengrui Zhu, et al. · Nature Communications · 104
PDF
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy
2015 · Mauricio Reginato, Sergey Karakashev · Cancer Management and Research · 103
PDF
The Oncogene HER2/neu (ERBB2) Requires the Hypoxia-inducible Factor HIF-1 for Mammary Tumor Growth and Anoikis Resistance
2013 · Kelly A. Whelan, Luciana P. Schwab, et al. · Journal of Biological Chemistry · 98
PDF
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
2021 · Jianhuang Lin, Heng Liu, et al. · Nature Communications · 56
PDF
Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2
2015 · Sergey V. Karakashev, Mauricio J. Reginato · Oncotarget · 47
PDF
Mouse models of epithelial ovarian cancer for preclinical studies
2021 · Sergey Karakashev, Ru-Gang Zhang · 动物学研究 · 42
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
2022 · Heng Liu, Jianhuang Lin, et al. · Cancer Immunology Research · 24
PDF
Ovarian Cancer: how can Resistance to Chemotherapy be Tackled?
2017 · Sergey Karakashev, Katherine M Aird · Future Oncology · 10
Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitors
2020 · Sergey Karakashev, Rugang Zhang · Molecular & Cellular Oncology · 9
PDF
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors
2025 · Gurushankar Chandramouly, William Fried, et al. · Journal of Medicinal Chemistry · 7
PDF
Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy
2024 · Sangeeta Kumari, Shraddha Gupta, et al. · Journal of Cellular Physiology · 6
PDF
Abstract NT-093: THE N6-METHYLATION OF ADENOSINE (M6A) IN FZD10 MRNA CONTRIBUTES TO RESISTANCE TO PARP INHIBITOR
2019 · Takeshi Fukumoto, Hengrui Zhu, et al. · Clinical Cancer Research · 2
Abstract 7239: Investigating the role of topoisomerase IIB in the regulation of antigen presentation pathway in high-grade serous ovarian cancer
2025 · Shraddha G. Gupta, Sangeeta Kumari, et al. · Cancer Research · 1
Abstract 1824: Hypoxia induces lapatinib resistance in ErbB2-positive breast cancer cells via regulation of DUSP2
2014 · Sergey Karakashev · Cancer Research · 1
CARM1-expressing ovarian cancers are selectively sensitive to HSP70 inhibition
2026 · Sangeeta Kumari, Shraddha Gupta, et al. · Molecular Therapy Oncology
Abstract 4833: Targeting DOT1L to enhance the immune response in ovarian cancer
2025 · Aisha Jamil, Shraddha Gupta, et al. · Cancer Research
Abstract 455: Targeting CARM1- expressing ovarian cancers with HSP-70 inhibitors
2025 · Sangeeta Kumari, Shraddha Gupta, et al. · Cancer Research
Data from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
2023 · Heng Liu, Jianhuang Lin, et al.
Supplementary Table from KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
2023 · Heng Liu, Jianhuang Lin, et al.
Works count: 51
Citation count: 1,379
H-index: 13
I10-index: 14
Year
Topic
Type